BioCardia Share Price

BioCardia Share Price

NASDAQ: BCDA | Micro Cap | Healthcare
$0.77
-$0.01 (-1.04%) Last updated on 19 Nov, 2026 | 01:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

BioCardia Stock Performance

Open
$0.77
Prev. Close
$0.78
Circuit Range
N/A
Day Range
$0.77 - $0.77
Year Range
$0.70 - $1.80
Volume
570
Average Traded
$0.77

BioCardia Share Price Today

As of 19 November 2026, BioCardia, Inc.'s share price is $0.77. The stock opened at $0.77, compared to its previous close of $0.78. During today's trading session, BioCardia, Inc.'s share price traded between $0.77 and $0.77, with an average price of $0.77. Over the past 52 weeks, the stock has recorded a high of $1.80 and a low of $0.70. In terms of performance, BioCardia, Inc.'s share price has declined by 16.71% over the last six months and is down 46.54% on a year-on-year basis.

BioCardia Share Price Chart

Line chart of the BioCardia price trend over the selected period. The price fell overall, ranging from 0.77 to 0.79, ending at 0.77.
$0.77$0.77
L
Show Current Price
H

BioCardia Stock Fundamentals & Key Indicators

Market Cap
$5.11M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.51
Revenue (TTM)
$0.00
Return On Equity (TTM)
-918.92%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
8.08%

BioCardia Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.98-$2.26-$1.61-$1.82
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-14.14%28.76%-13.04%

BioCardia Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.35$0.48$0.06$0.00
Net Profit-$11.91-$11.57-$7.95-$8.23
Net Profit Margin-882.22%-2410.42%-13250.00%N/A
Income ChangeN/A2.85%31.29%-3.52%

BioCardia Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.681.11.531.93
Current Assets2.732.621.467.86
Total Assets3.413.722.999.79
Non Current Liabilities0.090.570.981.32
Current Liabilities2.432.323.613.59
Total Liabilities2.522.894.594.9
Shareholders' Equity0.90.84-1.64.89

BioCardia Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-7.44-7.89-9.97-10.56
Investing-0.01-0.01-0.01-0.07
Financing7.579.163.735.12

Corporate Actions

Split
Ex-date: 30 May 2024

Split
Ex-date: 06 Jun 2019

About BioCardia

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

BioCardia Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.87
$0.77
-12.84%
Oct 2026
$1.03
$0.88
-14.98%
Sep 2026
$1.11
$1.03
-12.29%
Aug 2026
$0.85
$1.18
+46.40%
Jul 2026
$1.21
$0.81
-35.52%
Jun 2026
$0.90
$1.25
+35.72%
May 2026
$1.13
$0.92
-19.91%
Apr 2026
$1.17
$1.15
-1.29%
Mar 2026
$1.35
$1.17
-10.73%
Feb 2026
$1.12
$1.30
+6.10%
Jan 2026
$1.26
$1.23
-1.60%
Dec 2025
$1.42
$1.25
-12.89%

BioCardia Share Price FAQs